Metaplanet
3350
Nippon Telegraph & Telephone
9432
Mitsubishi Heavy Industries
7011
4
Remixpoint
3825
5
Mitsubishi UFJ Financial Group
8306
JP Stock MarketDetailed Quotes
4882 Perseus Proteomics
- 720
- +27+3.90%
20min DelayMarket Closed Mar 11 15:30 JST
10.61BMarket Cap-7.68P/E (Static)
720High667Low898.50KVolume683Open693Pre Close620.24MTurnover87652wk High6.52%Turnover Ratio14.74MShares29152wk Low-75.72EPS TTM9.93BFloat Cap1022Historical HighLossP/E (Static)13.79MShs Float255Historical Low-93.69EPS LYR7.65%Amplitude--Dividend TTM5.77P/B100Lot Size--Div YieldTTM
About Perseus Proteomics Company
Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody based therapeutics and diagnostics drugs to cure against cancer and other diseases.
Company Profile
Symbol4882
Company NamePerseus Proteomics
Founded2001-02-01
MarketTSE Growth
Fiscal Year Ends03-31
Address4-7-6, Komaba Tokyo Park Building, Meguro-ku
Zip Code103-0015
Phone03-6264-8268
Websitewww.ppmx.com
Company Executives
- Name
- Position
- Salary
- Shinji Hagiwara
- Director, Executive Officer and Head of Business Development Dept and Research and Development
- --
- Shinichi Suzukawa
- Director, Executive Officer and Head of Administrative Dept
- --
- Takuya Yokokawa
- Representative Director, President and Executive Officer
- --
- Takashi Ohno
- Director
- --
- Tatsuya Nagase
- Director
- --
- Tadashi Horiuchi
- Independent Director
- --
- Nobuo Hanai
- Independent Director
- --
- Kinichirou Kominami
- Independent Director
- --